• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Newsletter Archive
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Student Innovation Award

Established in 2023, the Student Innovation Award aims to raise awareness of ALS/MND within the global student community. It offers students a platform to showcase creative ideas that improve the quality of life for people living with ALS/MND and helps spark innovation in the field.

To be considered for the award, candidates must:

  • Be a full-time student or part of a student team
  • Have initiated and implemented a project that has the potential for international impact
  • Present an idea that is both innovative and grounded in the real needs of people living with ALS/MND
  • Demonstrate that the solution is both practical and accessible

The winning individual or team will receive a £1,000 honorarium.

The award is presented annually during the Alliance Meeting. If no suitable candidate is nominated in a given year, the award will not be granted. Please note that current Board of Directors are not eligible for nomination.

The 2026 nomination period is open. The deadline to submit your nominations is Tuesday, September 15. 

Student Innovation Award Nomination

  • (No self-nominations please)
  • Drop files here or
    Max. file size: 128 MB.
    • Please include sources or credits if they apply.
    • Drop files here or
      Max. file size: 128 MB.

       

      Primary Sidebar

      • Jorge Melo, Brazil

        Jorge Melo, Brazil

      • Margarita Pizarro, Argentina

        Margarita Pizarro, Argentina

      • Horacio Fritzer, Argentina

        Horacio Fritzer, Argentina

      • Emilienne Verhaegen, Belgium

        Emilienne Verhaegen, Belgium

      • Armando González Gómez, Colombia

        Armando González Gómez, Colombia

      • Danny Reviers, Belgium

        Danny Reviers, Belgium
        DannyReviers

      • Ana María Zavala, Mexico

        Ana María Zavala, Mexico

      • Elkin Ramiro Gaviria Muñoz, Colombia

        Elkin Ramiro Gaviria Muñoz, Colombia

      • Philip Brindle, England

        Philip Brindle, England

      • Colm Francis Davis, Ireland

        Colm Francis Davis, Ireland

      • Andres Estevez Guersznik, Ireland

        Andres Estevez Guersznik, Ireland

      • Steve

        Steve

      • Erwin Coppejans, Belgium

        Erwin Coppejans, Belgium

      • Imelda Arenas, Colombia

        Imelda Arenas, Colombia

      • Joyce Rusinak, USA

        Joyce Rusinak, USA

      • John Dinon, Australia

        John Dinon, Australia

      • Andrietta, Italy

        Andrietta, Italy
        Andrietta

      • Jette Odgaard Villemoes, Denmark

        Jette Odgaard Villemoes, Denmark

      • Christian Bär, Germany

        Christian Bär, Germany

      • Xian-Zhang Niu, China

        Xian-Zhang Niu, China

      • Chris McCauley, Canada

        Chris McCauley, Canada

      • Anthony Lynch, Australia

        Anthony Lynch, Australia

      • Zabun Nassar, England

        Zabun Nassar, England

      • Bayley, Australia

        Bayley, Australia

      • Bjarne Hytjanstorp, Norway

        Bjarne Hytjanstorp, Norway

      • Glen Victor Peters, Australia

        Glen Victor Peters, Australia

      • Jan Zuring, Netherlands

        Jan Zuring, Netherlands

      • Marcel R. Wernard, Netherlands

        Marcel R. Wernard, Netherlands

      • Zelina Brito, Brazil

        Zelina Brito, Brazil

      • David Hall, USA

        David Hall, USA

      • Luis Antonio Pimenta Lima, Brazil

        Luis Antonio Pimenta Lima, Brazil

      • Ian Roberts, Australia

        Ian Roberts, Australia

      • Brian Lovell, Australia

        Brian Lovell, Australia

      • Mike Cels, Canada

        Mike Cels, Canada

      • Robbie Caliste, UK

        Robbie Caliste, UK

      • Chirag Walia, India

        Chirag Walia, India
        ChiragWalia

      • Mike Small, UK

        Mike Small, UK

      • Dorette Lüdi, Switzerland

        Dorette Lüdi, Switzerland

      • Aida Trzmiel de Guterman, Argentina

        Aida Trzmiel de Guterman, Argentina

      • Brian Parsons, Canada

        Brian Parsons, Canada

      • João Marcos Andrietta, Brazil

        João Marcos Andrietta, Brazil

      • Jo Knowlton, Scotland

        Jo Knowlton, Scotland

      • Jon Newsome, USA

        Jon Newsome, USA

      • Liz Ogg, Scotland

        Liz Ogg, Scotland

      • Francisco Perez Palop, Spain

        Francisco Perez Palop, Spain

      • Peng Yi-Wen, Taiwan

        Peng Yi-Wen, Taiwan

      • Duncan Bayly, Australia

        Duncan Bayly, Australia

      • Len Johnrose, England

        Len Johnrose, England

      • Timothy Holman, Switzerland

        Timothy Holman, Switzerland

      • Sally Pauls, USA

        Sally Pauls, USA

      Learn more about the March of Faces

      Footer

      Stay connected to the global ALS/MND community.

      Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

       
      This field is for validation purposes and should be left unchanged.
      • Email
      • Facebook
      • LinkedIn
      • Twitter
      • YouTube
      Return to top of page

      Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

      Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


      Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login